Subcontracting Opportunities

Subcontracting allows small and disadvantaged businesses to substantially impact the federal procurement preference programs. Due to legislative mandates, federal prime contractors award billions of subcontracting dollars annually to small businesses — Small Business Subcontracting Plan requirements set forth in their contracts include requirements to track participation by veteran-owned, service-disabled veteran-owned, HUBZone, disadvantaged, and women-owned businesses.

USASpending.gov provides information on organizations who have a prime contractor relationship with the NCI. The current Frederick National Laboratory for Cancer Research (FNLCR) prime contractor has significant subcontracting opportunities — see FNLCR Acquisitions for further information.

NCI also maintains a list of its active Indefinite Delivery/Indefinite Quantity (ID/IQ) Prime Contractors. NCI encourages businesses to network and establish teaming arrangements to support these contracting vehicles, which are used to place a variety of orders for supplies and services through processes that do not involve public posting after the base ID/IQ contract(s) have been awarded.

Indefinite Delivery/Indefinite Quantity (ID/IQ) Prime Contractors
Contract # Contractor Name(s) Title & Brief Description From Article B.1. Base Period of Performance (Start-End Dates)
HHSN261201300008I Information Management Services, Inc. Computing Services for the Division of Cancer Prevention, NCI - provides programming and data management services including project management,  data management, computer programming, computing infrastructure services, website development and systems design and development. 05/10/2013 - 05/09/2020
HHSN261201400002I Technical Resources, Inc Cancer Prevention Clinical Trials Auditing and Informatics Support 05/30/2014 - 05/29/2019
HHSN261201400004I North American Association of Central Cancer Registries (NAACCR) The objective of this contract is provide support to the North American Association of Central Cancer Registries
(NMCCR) in order to make the National Cancer lnstitute's (NCI) cancer surveillance program more responsive to the needs of the division, institute, and nation, and more integrated with other partners within the national cancer surveillance enterprise.This contract focuses on three specific areas: (1) Strengthening the national capacity for collecting, analyzing, and using comparable cancer registry data for cancer surveillance and research. (2) Developing
and improving methods for assessing the quality and comparability of cancer registry data. This includes, but is not limited to timeliness, completeness, and accuracy. (3) Improving the efficiency and quality of registry operationsthrough promoting established standards, disseminating technical information, and facilitating collaboration among Federal, state, provincial and local registry professionals.
07/01/2014 - 06/30/2021
HHSN261201400005I Vignet (NMCCR) in order to make the National Cancer lnstitute's (NCI) cancer surveillance program more responsive to the needs of the division, institute, and nation, and more integrated with other partners within the national cancer surveillance enterprise.This contract focuses on three specific areas: (1) Strengthening the national capacity for collecting, analyzing, and using comparable cancer registry data for cancer surveillance and research. (2) Developing and improving methods for assessing the quality and comparability of cancer registry data. This includes, but is not limited to timeliness, completeness, and accuracy. (3) Improving the efficiency and quality of registry operations through promoting established standards, disseminating technical information, and facilitating collaboration among Federal, state, provincial and local registry professionals.  09/12/2014 - 09/11/2021
HHSN261201400006I CDM Group Technical Services for the NCI Applied Research Program - This contract provides a broad range of developmental and technical services related to cancer-associated health behaviors, health services and outcomes for cancer treatment. The services include study management, questionnaire development, and database development and management. 09/12/2014 - 09/11/2021
HHSN261201400007I Gunnison Technical Services for the NCI Applied Research Program - This contract provides a broad range of developmental and technical services related to cancer-associated health behaviors, health services and outcomes for cancer treatment. The services include study management, questionnaire development, and database development and management. 09/12/2014 - 09/11/2021
HHSN261201400008I Vsolvit Technical Services for the NCI Applied Research Program - This contract provides a broad range of developmental and technical services related to cancer-associated health behaviors, health services and outcomes for cancer treatment. The services include study management, questionnaire development, and database development and management. 09/12/2014 - 09/11/2021
HHSN261201600007I Westat, Inc The Contractor shall provide support for centralized follow-up of participants from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening and the National Lung Screening (NLST) Trials. The PLCO was designed to determine if screening for prostate, lung, colorectal and ovarian cancer can reduce mortality from these cancers. The National Lung Screening Trial (NLST) was a randomized controlled trial designed to determine whether screening for lung cancer with low-dose helical computed tomography (CT) reduces mortality from lung cancer in high-risk individuals relative to screening with chest radiography. 03/01/2016 - 02/28/2021
HHSN261201700004I Bizzell Group Tobacco Control Research Scientific and Technical Services Support 09/01/2017 - 08/31/2022
HHSN261201700015I Nationwide Children's Hospital Biospcimen Core Resource (BCR) 08/25/2017 - 08/24/2022
HHSN26120180002I Connecticut Department of Public Health Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800003I Emory University Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800004I  Fred Hutchinson Cancer Research Center Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800005I Health Research, Inc. Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800006I  Idaho Hospital Association Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800007I  Louisiana State University Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800008I  Massachusetts Department of Public Health Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800009I  Public Health Institute Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800010I  Cancer Prevention Institute of California (CPIC) Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800011I  University of Hawaii Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800012I  University of Iowa Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800013I  University of Kentucky (Research Foundation)  Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800014I  University of New Mexico Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800015I  University of Southern California Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800016I  University of Utah Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800017I  Wisconsin Department of Health Services Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 05/1/2018 - 04/30/2028
HHSN261201800031I UCSF The Contractor shall collect population-based cancer data and report on population-based cancer incidence,
treatment, and survival data on all patients in the legally described geographic coverage area. The Contractor shall
participate in cancer surveillance research efforts supported under the Statement of Work. These may include
activities such as the Virtual Tissue Repository, Virtual Pooled Registry, Patterns of Care Studies, and other ancillary
studies.
05/1/2018 - 04/30/2028
HHSN2612013000028I Westat To provide administrative, regulatory, logistical, and information technology support for the Cancer Trials Support Unit (CTSU) to gain operational efficiency for both CTSU and NCTN/MCOs, enhance proficiency, and deliver measurable business value. The Contractor shall build and maintain the operational infrastructure of the CTSU as described within the Statement of Work (SOW). 08/31/2013 - 08/30/2020
HHSN261201300029I PPD To provide administrative, regulatory, logistical, and information technology support for the Cancer Trials Support Unit (CTSU) to gain operational efficiency for both CTSU and NCTN/MCOs, enhance proficiency, and deliver measurable business value. The Contractor shall build and maintain the operational infrastructure of the CTSU as described within the Statement of Work (SOW). 08/31/2013 - 08/30/2020
HHSN261201400010I Social and Scientific Systems, Inc This contract is for support of the Radiation Epidemiology Branch for all phases of epidemiologic studies including initiation of pilot and full-scale field studies, coordination of multi-center studies, arranging for cooperation between NCI and its collaborators, support for study data collection, data acquisition and cleaning, and collection of biological specimens in the US and abroad. It is anticipated that the Contractor will need to provide support to 8-30 studies annually. 08/31/2014 - 09/29/2019
HHSN261201700003I American Type Culture Collection  The Contractor shall provide Molecular Epidemiology Assay Support (MEAS) to the Division of Cancer Epidemiology and Genectics. 05/06/2017 - 03/05/2022
HHSN261201800020I Henry Ford Health System The Contractor shall recruit and retain participants, collect and process biospecimens, administer online questionnaires, and link to electronic medical records in support DCEG's NextGeneration Cohort  06/04/2018 - 06/03/2028
HHSN261201800021I Kaiser Foundation Hospitals The Contractor shall recruit and retain participants, collect and process biospecimens, administer online questionnaires, and link to electronic medical records in support DCEG's NextGeneration Cohort  06/04/2018 - 06/03/2028
HHSN261201800022I Sanford Research The Contractor shall recruit and retain participants, collect and process biospecimens, administer online questionnaires, and link to electronic medical records in support DCEG's NextGeneration Cohort  06/04/2018 - 06/03/2028
HHSN261201800023I The University of Chicago The Contractor shall recruit and retain participants, collect and process biospecimens, administer online questionnaires, and link to electronic medical records in support DCEG's NextGeneration Cohort  06/04/2018 - 06/03/2028
HHSN261201700009I Metabolon, Inc. The Contractor shall provide metabolomic profiling services for DCEG studies using liquid chromatography and gas chromatography mass spectrometry (LC-MS). 06/14/2017 - 06/13/2022
HHSN261201700012I  Fundacion INCIENSA Evaluation of Single Dose Protection Afforded by the Prophylactic HPV vaccines 08/01/2017 - 07/31/2023
HHSN261201800033I Medidata Solutions Rave Hosting, Maintenance,  and Professional Services, and License, Hosting, Maintenance, and Professional Services for Rave integrated anicillary services. 09/01/2018 - 08/31/2023
HHSN261201500003I Leidos Biomedical Research OTS Contractor maintains flexibility and is rapidly responsive in supporting the evolving on-going research, emerging technologies and new research initiatives of the Government.  Moreover, it is vital that the requirements of the Government be addressed proactively and that creativity and innovation be used in the performance of all aspects of this Statement of Work. 09/14/2015 - 08/30/2019
HHSN261201600015I IITRI Preclinical Toxicology Study of Drugs Developed for Cancer and Other Diseases 07/01/2016 - 06/30/2021
HHSN261201600016I Battelle Preclinical Toxicology Study of Drugs Developed for Cancer and Other Diseases 07/01/2016 - 06/30/2022
HHSN261201600017I SRI Preclinical Toxicology Study of Drugs Developed for Cancer and Other Diseases 07/01/2016 - 06/30/2023
HHSN261201600018I Southern Preclinical Toxicology Study of Drugs Developed for Cancer and Other Diseases 07/01/2016 - 06/30/2024
HHSN261201600019I UIC Preclinical Toxicology Study of Drugs Developed for Cancer and Other Diseases 07/01/2016 - 06/30/2025
HHSN261201800036I Synergy NCI Center for Global Health, Logistics, Data Analysis and Technical Support 09/17/2018 - 09/16/2023
HHSN261201700007I Alchem Synthesis of Non-GMP Small Molecules 09/18/2017 - 09/17/2022
HHSN261201600002I 22nd Century Technologies Inc. SharePoint Maintenance & Support Services (NCCIH & NCI) 10/17/2015 - 10/16/2020
75N91019D00012 IIT Research Institute PREVENT Preclinical Drug Development Program (Efficacy Pool) 01/25/2019 - 01/24/2024
75N91019D00014 SRI International PREVENT Efficacy studies 01/25/2019 - 01/24/2024
75N91019D00016 Illinois Univ, TRL PREVENT Efficacy studies 01/25/2019 - 01/24/2024
75N91019D00021 University of Texas, MD Anderson PREVENT Efficacy studies 01/25/2019 - 01/24/2024
75N91019D00022 The Research Institute of Fox Chase Cancer Center PREVENT Efficacy studies 01/25/2019 - 01/24/2024
75N91019D00013 IIT Research Institute PREVENT Preclinical Drug Development Program (Toxicology Pool) 01/25/2019 - 01/24/2024
75N91019D00018 Southern Research Institute PREVENT Preclinical Drug Development Program (Toxicology Pool) 01/25/2019 - 01/24/2024
75N91019D00017 Illinois Univ, TRL PREVENT Efficacy studies 01/25/2019 - 01/24/2024
75N91019D00019 University of Alabama at Birmingham PREVENT Efficacy studies 01/25/2019 - 01/24/2024
75N91019D00020 University of Oklahoma Health Sciences Center PREVENT Efficacy studies 01/25/2019 - 01/24/2024
HHSN261201500002B Information Management Services (IMS) The purpose of this acquisition is to provide computer systems analysis, programming, data management and maintenance, data analysis, statistical reporting, and documentation services for research efforts conducted by the National Cancer Institute (NCI). Tasks associated with this work include statistical programming and analytic consultation; systems analysis, design, programming, testing documentation maintenance support for computer systems; management, data entry, editing, file management, documentation, and program maintenance support for NCI databases; and computer system administration and resources to support analytic processing, client/server applications, web server applications, and file transfer options in a secure, firewall-protected environment. 08/1/2015 - 07/27/2020
HHSN261201600006I Fisher BioServices Inc NCI is seeking support services to operate and maintain the National Cancer Institute's Chemotherapeutic Agents Repository (NCI-CAR).  The principal goals of this contract are 1) to support compound acquisition activities related to the DTP anticancer pre-clinical drug evaluation program which seeks to identify new small molecule therapeutic agents and 2) distribution of chemicals to intramural and extramural investigators for research purposes. The primary tasks of the contract are the receipt, registration, storage, analysis, arraying and distribution of small molecules and purified natural products.  This contract is also responsible for providing an informational interface with NCI and external investigators that are submitting or requesting research compounds; for updating of the chemical database which includes chemical, inventory, receiving and shipping information; systematic file and record keeping of both current and archival information related to Repository activities; and reacquisition of samples for continued chemical and biological studies.     03/1/2016 - 02/28/2021
HHSN261201600020I SRI International The pupose of this acquisition is to continue implementation of bioanalytical methods and to conduct pharmacokinetic evaluations in aniamls with compounds of interest to the NCI Therapeutics (NeXT) Program.  07/01/2016 - 06/30/2021
HHSN261201600021I Southern Research The pupose of this acquisition is to continue implementation of bioanalytical methods and to conduct pharmacokinetic evaluations in aniamls with compounds of interest to the NCI Therapeutics (NeXT) Program.  07/01/2016 - 06/30/2021
HHSN261201600022I University of Pittsburgh The pupose of this acquisition is to continue implementation of bioanalytical methods and to conduct pharmacokinetic evaluations in aniamls with compounds of interest to the NCI Therapeutics (NeXT) Program.  07/01/2016 - 06/30/2021
HHSN261201600023I IITRI  The pupose of this acquisition is to continue implementation of bioanalytical methods and to conduct pharmacokinetic evaluations in aniamls with compounds of interest to the NCI Therapeutics (NeXT) Program.  07/01/2016 - 06/30/2021
HHSN261201600024I Mayo Clinic The pupose of this acquisition is to continue implementation of bioanalytical methods and to conduct pharmacokinetic evaluations in aniamls with compounds of interest to the NCI Therapeutics (NeXT) Program.  07/01/2016 - 06/30/2021
HHSN261201500034I ASTERAND US ACQUISITION CORP Tissue source site for CPTAC Program 09/22/2015 - 09/21/2020
HHSN261201500046I BIOMATRIX Tissue source site for CPTAC Program 09/29/2015 - 09/28/2020
HHSN261201500047I GLOBAL BIOCLINICAL Tissue source site for CPTAC Program 09/29/2015 - 09/28/2020
HHSN261201600003I INTERNATIONAL GENOMICS CONSORTIUM Tissue source site for CPTAC Program 01/15/2016 - 01/14/2021
HHSN261201600004I ANALYTICAL BIOLOGICAL SERVICES Tissue source site for CPTAC Program 01/19/2016 - 01/18/2021
HHSN261201600005I IIMO (POLAND) Tissue source site for CPTAC Program 12/30/2015 - 12/29/2020
HHSN261201600008I CEDARS-SINAI MEDICAL CENTER Tissue source site for CPTAC Program 03/2/2016 - 03/1/2021
HHSN261201600009I BEAUMONT HEALTH Tissue source site for CPTAC Program 02/24/2016 - 02/23/2021
HHSN261201600010I U. OF CALIFORNIA SAN DIEGO  Tissue source site for CPTAC Program 03/23/2016 - 03/22/2021
HHSN261201600011I BOSTON MEDICAL CENTER Tissue source site for CPTAC Program 02/24/2016 - 02/23/2021
HHSN261201600012I BIOPARTNERS Tissue source site for CPTAC Program 02/24/2016 - 02/23/2021
HHSN261201600026I  Centeva, LLC Information Technology Systems & Support for NCI OA 09/29/2016 - 09/28/2019
HHSN261201700011I MRIGlobal Analysis of bulk drug samples and their
pharmaceutical formulations
08/1/2017 - 07/31/2022
HHSN261201700013I RTI International Analysis of bulk drug samples and their
pharmaceutical formulations
08/1/2017 - 07/31/2022
HHSN261201700014I SRI International Analysis of bulk drug samples and their
pharmaceutical formulations
08/1/2017 - 07/31/2022
HHSN261201500009I IriSys, LLC Discovery and development of new therapeutic agents for treatment of cancer 06/30/2015 - 06/29/2020
HHSN261201500010I Evotec (US), Inc. Store and maintain the CBCSLC approximately 135,000 small molecule screening collections 09/30/2015 - 09/29/2020
HHSN261201500005I The Hospital for Sick Children Laboratory Testing Services of Serum Enzymes for Patients at Risk of Shwachman-Diamond Syndrome 04/15/2015 - 04/14/2020
HHSN261201500007I Oregon Health & Science University Laboratory Testing Services of Chromosome Breakage Analyses for the

Inherited Bone Marrow Failure Study
05/20/2015 - 05/19/2020
HHSN261201500044I Datawaves Technology Transfer Center TIMS database Maintenance and Upgrades 09/20/2015 (eff. Date 09/24/2015) - 09/19/2020
HHSN261201500045I Repeat Diagnostics, Inc. Laboratory Testing Services of Telomere Length Assays for the Inherited Bone Marrow Failure Study 09/20/2015 (eff. Date 09/22/2015) - 09/19/2020
HHSN261201400020I Centeva, LLC Services for support of the National Cancer
Institutes Office of Acquisitions (NCI OA)
Information Technology Systems
09/29/2014 - 09/28/2019
HHSN261201700019I Bayer Healthcare LLC BPX30 Disposable Endorectal Coils for 3.OT MRI Scanner 09/10/2017 - 09/17/2022
HHSN261201500012I Bayer Healthcare Procurement of Coil, Disposable Endorectal 3.0T 07/15/2015 - 07/14/2020
HHSN261201500017I Universite Laval Services to determine serum concentrations of
samples collected by the Hormonal and
Reproductive Epidemiology Branch (HREB).
09/01/2015 - 08/31/2020
HHSN261201500033I Artificial Intelligence in Medicine Surveillance Epidemiology and End Results (SEER) Electronic Data Capture Software Support and Installations 09/26/2015 - 09/25/2020
HHSN261201400019I Clontech Laboratories, Inc. GMP Grade Retronectin 09/30/2014 - 09/21/2019
HHSN261201500016I Gene Dx Clinical Genetic Testing for TP53 08/10/2015 - 08/9/2020
HHSN261201400012I Asclepius Solutions NCI Budget Management System (BMS); Content Mangement System (CMS); and Referral Connect Services and Support 08/26/2014 - 08/25/2019
HHSN261201400011I Scientific Consulting Group Applied Research Program (ARP) Meeting and Working Group Support 8/15/2014 - 08/14/2019
HHSN261201700003B ICF Incorporated, LLC Communication Services for NCI/DCCPS 09/22/2017 - 09/29/2022
HHSN261201700018I PR Strategists LLC Stratefic Workforce Planning and Executive Coaching 09/08/2017 - 09/10/2022
HHSN261201700017I Genepria Consulting Inc. Statistical and Programming Appplications 09/12/2017 - 09/11/2022
HHSN 261201700010I Roche Diagnostics Corporation BenchMark Ultra Reagents and Consumables 06/22/2017 - 06/21/2019
HHSN261201700006I Leland Standord Junior Univerisity Laboratory Services for HDV Antibody (anti0HDV), RNA and genotype testing 04/03/2017 - 04/02/2020
HHSN261201800019I Olink Proteonimes Testing Samples Using Inflammation and Cardiometabolic Panels  05/01/2018 - 04/30/2020
HHSN261201800025I Becton, Dickinson and Company Reagent, rental equipment, product supply, and maintenance for equipment in the Laboratory of Pathology 06/28/2018 - 06/27/2018
HHSN261201400019I TAKARA BIO USA, INC. GMP grade RetroNectin 09/30/2014 - 09/29/2019
HHSN261201600025I Ganges, Mary Bruce Biological Research Consultant Tissue Culture technician support p to 9000 hours with a minimum of 1400 hours 08/20/2016 - 08/19/2021
HHSN261201600027I Vanderbilt University Medical Center Laboratory Testing Services for Circulating Inflammation Markers and Prospective Risk of Gastric Cancer Related to the H Pylor  09/14/2016 - 09/13/2021
HHSN261201600030I Invitae Corporation Lab Testing/Dicer I Genetic Testing 09/19/2016 - 09/21/2021
HHSN261201800034I D's Ventures LLC Procurement of Gardasil-9 Vaccines in support of NCI/CCR 9/18/2018 - 9/18/2021